Udaipur-based agrochemical & life-sciences maker: crop protection, CSM custom synthesis, pharma APIs.
Price
Market Cap
Sector
Commodities
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 14 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 2.6k | 5.3k | 6.1k | 7.2k | 8.7k | 10.1k | 10.8k | 11.2k |
| Borrowings | 519 | 373 | 316 | 46 | 191 | 184 | 242 | 342 |
| Other Liabilities | 1.1k | 1.3k | 1.4k | 1.2k | 1.8k | 1.9k | 2.2k | 1.8k |
| Total Liabilities | 4.2k | 7.0k | 7.8k | 8.5k | 10.7k | 12.2k | 13.3k | 13.4k |
| AssetsFixed Assets | 1.9k | 2.1k | 2.5k | 2.6k | 3.5k | 4.2k | 4.4k | 4.6k |
| CWIP | 271 | 288 | 114 | 132 | 278 | 550 | 610 | 1.0k |
| Investments | 150 | 872 | 900 | 1.0k | 1.3k | 1.5k | 1.4k | 1.4k |
| Other Assets | 1.9k | 3.7k | 4.3k | 4.7k | 5.6k | 6.0k | 6.9k | 6.4k |
| Total Assets | 4.2k | 7.0k | 7.8k | 8.5k | 10.7k | 12.2k | 13.3k | 13.4k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 391 | 698 | 725 | 529 | 1.5k | 2.0k | 1.4k | 474 |
| Cash from Investing | -322 | -985 | -2.4k | -110 | -496 | -1.8k | -1.4k | -612 |
| Cash from Financing | -125 | 350 | 1.7k | -177 | -483 | -222 | -286 | -171 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 23 | 29 | 287 | 192 | 1.2k | 1.4k | 575 | -632 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (34.9×) and current (32.2×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 2.4% growth and a 32× exit, ₹2804 only delivers your return if you pay ₹1,302. The price is currently baking in 18% growth.
EPS grows 2.4%/yr for 5 years, then fades to 6% over 2, exits at 32×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 2.4% | 89.15 |
| FY28 | 2.4% | 91.29 |
| FY29 | 2.4% | 93.48 |
| FY30 | 2.4% | 95.72 |
| FY31 | 2.4% | 98.02 |
| FY32 | 4.2% ·fade | 102.14 |
| FY33 | 6.0% ·fade | 108.27 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.